Bevacizumab and Lomustine for Recurrent GBM
Clinical trial NCT01290939 · COMPLETED
Trial details
- NCT number
- NCT01290939
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.